David Digomann

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Cancer Stem Cells

Long Non Coding Rna

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

David Digomann, Max Heiduk, Charlotte Reiche, Jessica Glück, Christoph Kahlert, Peter Mirtschink, Anna Klimova, Florian Bösch, Torsten Tonn, Jochen Gaedcke, Michael Ghadimi, Jürgen Weitz, Lena Seifert, Adrian M Seifert
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer. NPJ precision oncology 7 (1) (2023)
Max Heiduk, Anna Klimova, Charlotte Reiche, David Digomann, Carolin Beer, Daniela E Aust, Marius Distler, Jürgen Weitz, Adrian M Seifert, Lena Seifert
TIGIT expression delineates T cell populations with distinct functional and prognostic impact in pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
David Digomann, Johannes Strack, Max Heiduk, Ioana Plesca, Luise Rupp, Charlotte Reiche, Simone Nicolaus, Carolin Beer, Ulrich Sommer, Marc Schmitz, Marius Distler, Jürgen Weitz, Adrian M Seifert, Lena Seifert
VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer. Cancers 15 (8) (2023)
David Digomann, Johannes Strack, Max Heiduk, Ioana Plesca, Luise Rupp, Charlotte Reiche, Simone Nicolaus, Carolin Beer, Ulrich Sommer, Marc Schmitz, Marius Distler, Jürgen Weitz, Adrian M Seifert, Lena Seifert
VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer. Cancers 15 (8) (2023)
David Digomann, Annett Linge, Anna Dubrovska
SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed. Autophagy 15 (10) (2019)